Drug intelligence / Profile preview

povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + bupivacaine

Development stage: Unknown
Lead developer: Rx Pharma-pack
Modality: Small Molecules
Administration: Topical, Parenteral, Intradermal, Epidural, Intrathecal

Overview

This product is a **combination anesthetic and antiseptic kit** containing povidone-iodine, lidocaine hydrochloride, isopropyl alcohol, and bupivacaine. It is used in procedural settings to prepare the skin and provide local or regional anesthesia or analgesia for surgical, diagnostic, therapeutic, and obstetrical procedures. The anesthetic components, lidocaine and bupivacaine, are **small-molecule amide local anesthetics** that inhibit impulse initiation and conduction in nerves primarily by reversible blockade of voltage-gated sodium channels, while povidone-iodine and isopropyl alcohol function as topical antiseptics to disinfect the application or injection site. Based on the provided context, this appears to be a bundled or kit-based point-of-care product rather than a distinct traditionally FDA-approved single-entity branded drug program, and no unique sponsor-specific development code or clearly attributable proprietary developer was identified.

Brand names: POINT OF CARE LM 2.2
Other names: povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + bupivacaine

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + bupivacaine.

Explore the full profile